Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Please provide your email address to receive an email when new articles are posted on . Some Black smokers had worse COPD classification after use of race-neutral vs. race-specific lung function ...

Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an ...

Using composite endpoints to predict clinically important deterioration in chronic obstructive pulmonary disease (COPD) could help investigators assess disease activity in clinical trials and better ...

Both agents are long-acting muscarinic antagonists. The primary endpoint of the study was the change from baseline in trough FEV 1 at day 85. Findings showed no statistically significant difference ...

Spirometry test There is significant disparity in the ratios for postbronchodilator FEV1/FEV6 and FEV1/FVC %, and this disparity is very pronounced in women. Disclosure: One study author declared ...

Lung volume reduction surgery (LVRS) is a treatment for end-stage lung disease caused by emphysema. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that causes shortness of breath ...